Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth 
via p75(NTR)/NgR-independent pathways that converge at RhoA

Schweigreiter, R.; Walmsley, A. R.; Niederost, B.; Zimmermann, D. R.; Oertle, T.; Casademunt, E.; Frentzel, S.; Dechant, G.; Mir, A.; Bandtlow, C. E.

doi:10.1016/j.mcn.2004.06.004

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75(NTR)/NgR-independent pathways that converge at RhoA

MPS-Authors

/persons/resource/persons273432

Casademunt, E.
Department: Neurobiochemie / Barde, MPI of Neurobiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Schweigreiter, R., Walmsley, A. R., Niederost, B., Zimmermann, D. R., Oertle, T., Casademunt, E., et al. (2004). Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75(NTR)/NgR-independent pathways that converge at RhoA. Molecular and Cellular Neuroscience, 27(2), 163-174. doi:10.1016/j.mcn.2004.06.004.

Cite as: https://hdl.handle.net/21.11116/0000-000A-694E-A

Abstract

There is no abstract available